van de Stadt, E.A.; Yaqub, M.; Schuit, R.C.; Bartelink, I.H.; Leeuwerik, A.F.; Schwarte, L.A.; de Langen, A.J.; Hendrikse, H.; Bahce, I.
Relationship between Biodistribution and Tracer Kinetics of 11C-Erlotinib, 18F-Afatinib and 11C-Osimertinib and Image Quality Evaluation Using Pharmacokinetic/Pharmacodynamic Analysis in Advanced Stage Non-Small Cell Lung Cancer Patients. Diagnostics 2022, 12, 883.
https://doi.org/10.3390/diagnostics12040883
AMA Style
van de Stadt EA, Yaqub M, Schuit RC, Bartelink IH, Leeuwerik AF, Schwarte LA, de Langen AJ, Hendrikse H, Bahce I.
Relationship between Biodistribution and Tracer Kinetics of 11C-Erlotinib, 18F-Afatinib and 11C-Osimertinib and Image Quality Evaluation Using Pharmacokinetic/Pharmacodynamic Analysis in Advanced Stage Non-Small Cell Lung Cancer Patients. Diagnostics. 2022; 12(4):883.
https://doi.org/10.3390/diagnostics12040883
Chicago/Turabian Style
van de Stadt, Eveline Annette, Maqsood Yaqub, Robert C. Schuit, Imke H. Bartelink, Anke F. Leeuwerik, Lothar A. Schwarte, Adrianus J. de Langen, Harry Hendrikse, and Idris Bahce.
2022. "Relationship between Biodistribution and Tracer Kinetics of 11C-Erlotinib, 18F-Afatinib and 11C-Osimertinib and Image Quality Evaluation Using Pharmacokinetic/Pharmacodynamic Analysis in Advanced Stage Non-Small Cell Lung Cancer Patients" Diagnostics 12, no. 4: 883.
https://doi.org/10.3390/diagnostics12040883
APA Style
van de Stadt, E. A., Yaqub, M., Schuit, R. C., Bartelink, I. H., Leeuwerik, A. F., Schwarte, L. A., de Langen, A. J., Hendrikse, H., & Bahce, I.
(2022). Relationship between Biodistribution and Tracer Kinetics of 11C-Erlotinib, 18F-Afatinib and 11C-Osimertinib and Image Quality Evaluation Using Pharmacokinetic/Pharmacodynamic Analysis in Advanced Stage Non-Small Cell Lung Cancer Patients. Diagnostics, 12(4), 883.
https://doi.org/10.3390/diagnostics12040883
